![]() |
Name |
6-deacetoxyhelvolic acid
|
Molecular Formula | C33H48O9 | |
IUPAC Name* |
2-(6,16-diacetyloxy-4,8,10,14-tetramethyl-3,7-dioxo-2,4,5,6,9,11,12,13,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ylidene)-6-hydroxy-6-methylheptanoicacid
|
|
SMILES |
CC(=O)OC1CC2(C)C(CCC3C4(C)CCC(=O)C(C)C4C(OC(C)=O)C(=O)C32C)C1=C(CCCC(C)(C)O)C(=O)O
|
|
InChI |
InChI=1S/C33H48O9/c1-17-22(36)13-15-31(6)24-12-11-21-25(20(29(38)39)10-9-14-30(4,5)40)23(41-18(2)34)16-32(21,7)33(24,8)28(37)27(26(17)31)42-19(3)35/h17,21,23-24,26-27,40H,9-16H2,1-8H3,(H,38,39)/b25-20-/t17-,21+,23+,24+,26-,27+,31-,32+,33-/m1/s1
|
|
InChIKey |
ITBJGRBIGKDZTI-GAZAAFLYSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 588.74 | ALogp: | 4.8 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 144.3 | Aromatic Rings: | 4 |
Heavy Atoms: | 42 | QED Weighted: | 0.302 |
Caco-2 Permeability: | -5.281 | MDCK Permeability: | 0.00001460 |
Pgp-inhibitor: | 0.885 | Pgp-substrate: | 0.141 |
Human Intestinal Absorption (HIA): | 0.45 | 20% Bioavailability (F20%): | 0.045 |
30% Bioavailability (F30%): | 0.872 |
Blood-Brain-Barrier Penetration (BBB): | 0.91 | Plasma Protein Binding (PPB): | 84.18% |
Volume Distribution (VD): | 0.505 | Fu: | 16.76% |
CYP1A2-inhibitor: | 0.001 | CYP1A2-substrate: | 0.092 |
CYP2C19-inhibitor: | 0.007 | CYP2C19-substrate: | 0.793 |
CYP2C9-inhibitor: | 0.04 | CYP2C9-substrate: | 0.209 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.074 |
CYP3A4-inhibitor: | 0.114 | CYP3A4-substrate: | 0.191 |
Clearance (CL): | 3.956 | Half-life (T1/2): | 0.326 |
hERG Blockers: | 0 | Human Hepatotoxicity (H-HT): | 0.072 |
Drug-inuced Liver Injury (DILI): | 0.579 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.99 | Maximum Recommended Daily Dose: | 0.087 |
Skin Sensitization: | 0.017 | Carcinogencity: | 0.126 |
Eye Corrosion: | 0.014 | Eye Irritation: | 0.031 |
Respiratory Toxicity: | 0.528 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002467 | ![]() |
0.803 | D0X7XG | ![]() |
0.429 | ||
ENC005154 | ![]() |
0.790 | D0H2MO | ![]() |
0.272 | ||
ENC005236 | ![]() |
0.790 | D09IEE | ![]() |
0.270 | ||
ENC003848 | ![]() |
0.756 | D08BDT | ![]() |
0.267 | ||
ENC001480 | ![]() |
0.630 | D0X4RS | ![]() |
0.267 | ||
ENC005487 | ![]() |
0.616 | D01ZOG | ![]() |
0.261 | ||
ENC003484 | ![]() |
0.559 | D0G7KJ | ![]() |
0.259 | ||
ENC003780 | ![]() |
0.547 | D0X2LV | ![]() |
0.256 | ||
ENC005155 | ![]() |
0.511 | D0T2PL | ![]() |
0.253 | ||
ENC005151 | ![]() |
0.433 | D04SFH | ![]() |
0.252 |